Livzon Pharmaceutical Group Inc. (Livzon Pharma) announced on 23 April 2026 that four key corporate documents—the 2025 Annual Report, a circular dated the same day, the notice and proxy form for the 2025 Annual General Meeting (AGM), and the notice and proxy form for the 2026 First Class Meeting of H-Shareholders—have been released on both the company’s website (www.livzon.com.cn) and the HKEXnews portal (www.hkexnews.hk).

The company is encouraging shareholders to access these materials online and to adopt electronic communication for all future corporate documents. Registered shareholders who have already opted for printed copies will receive the current set by mail. Those who encounter difficulties with electronic access, or who prefer physical documents, may submit the enclosed Request Form to the Hong Kong branch share registrar, Tricor Investor Services Ltd., to obtain hard copies at no cost.

Livzon Pharma highlighted the importance of maintaining a valid email address on file. Shareholders who have not provided, or wish to update, their email address should complete the Request Form and return it to the registrar or send the details to 1513-ecom@vistra.com. Until a functional email address is registered, shareholders will receive notices of publication and actionable corporate communications solely in printed form.

Enquiries regarding the notification can be directed to Tricor’s hotline at (+852) 2980 1333 between 9:00 a.m. and 6:00 p.m., Monday to Friday (excluding public holidays).